Biocon Limited Q3 FY23 Investor Presentation February 2023

Biocon Limited presents its Q3 FY23 financial and operational results as a global biopharmaceutical leader. The company operates with revenue of ₹8,397 Cr (~$1.1 bn) and serves over 120 countries with innovative, affordable therapies across 7 manufacturing facilities.